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A molecular communications model for drug
delivery
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Abstract—This paper considers the scenario of a targeted
drug delivery system, which consists of deploying a number
of biological nanomachines close to a biological target (e.g. a
tumor), able to deliver drug molecules in the diseased area.
Suitably located transmitters are designed to release a continuous
flow of drug molecules in the surrounding environment, where
they diffuse and reach the target. These molecules are received
when they chemically react with compliant receptors deployed
on the receiver surface. In these conditions, if the release rate
is relatively high and the drug absorption time is significant,
congestion may happen, essentially at the receiver site. This
phenomenon limits the drug absorption rate and makes the
signal transmission ineffective, with an undesired diffusion of
drug molecules elsewhere in the body. The original contribution
of this paper consists of a theoretical analysis of the causes of
congestion in diffusion-based molecular communications. For this
purpose, it is proposed a reception model consisting of a set
of pure loss queuing systems. The proposed model exhibits an
excellent agreement with the results of a simulation campaign
made by using the Biological and Nano-Scale communication
simulator version 2 (BiNS2), a well-known simulator for molecu-
lar communications, whose reliability has been assessed through
in-vitro experiments. The obtained results can be used in rate
control algorithms to optimally determine the optimal release
rate of molecules in drug delivery applications.
Index Terms—Drug delivery, molecular communications, dif-
fusion, congestion, service time, queuing model.
I. Introduction
Molecular communication is a novel paradigm allowing
information exchange between biological nanomachines (bio-
nanomachines) over short ranges, within an aqueous envi-
ronment [1]. In this model, a transmitter nanomachine emits
molecules, which propagate and eventually are received by
a receiver nanomachine. The information is usually encoded
in either the timing or the amplitude of the concentration of
molecules. The reception process usually consists of a chem-
ical reaction between those molecules (ligand) and compliant
receptors present on the receiver surface. Bio-nanomachines
are made of biological materials and can perform a number
of simple tasks which need to be coordinated, by means of
message exchange, in order to accomplish complex functions.
Diffusion-based molecular communications are a special
form of molecular communications [2], very common in
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nature. They can be roughly classified in two categories,
namely pure-diffusion and diffusion with drift. For instance,
the former includes communications in the extracellular matrix
of the connective tissue, whilst the latter encompasses com-
munications in circulatory and lymphatic systems.
In this paper, we consider drug delivery in pure-diffusion
molecular communications. In drug delivery systems a nearly
continuous flow of molecules is transmitted from the transmit-
ter (TX) to the receiver (RX) [3], in order to achieve a desired
effective average drug delivery rate at a specific target. In these
applications, the TX node has the role of an actuator, and the
RX node is either the target or a sensor which measures and
controls the delivery of drug/grow factors molecules to the
surrounding cells.
In this scenario, the space around the receiver could become
full of drug molecules, which produce congestion. Congestion
control in packet networks is a research topic that attracted
researchers in the last 30 years (see, e.g., [4], [5]), since the
seminal works of Van Jacobson [6] and K.K. Ramakrishnan
[7]. However, until now, little attention has been paid to
the issue of congestion in molecular communications, be-
yond some initial investigations reported in [8], [9]. Indeed,
molecular communications, especially those making use of
diffusion-based propagation [10], are not only very sensitive
to congestion, but also difficult to control due to the high
communication latency. Thus, an early detection of congestion
is necessary in order to avoid heavy receiver overload. How-
ever, beforehand, we have to give a definition of congestion
in molecular communications.
In molecular communications, congestion consists in the
inability of receivers to capture all molecules in the receptor
space. This limitation is due to the combination of two factors,
which are the number of receptors present over the receiver
surface and the trafficking time [11], which can be regarded
as the molecule reception time. The trafficking time is defined
as the time needed to make a binding between a ligand and
a compliant receptor, plus the time to internalize the resulting
complex, plus the time to re-expose another receptor. It can
last up to tens of seconds [11] and significantly affect the
molecule absorption process.
Motivation: in the bio-medical field, the receiver congestion
problem is referred to as “receptor saturation”. Building a
model for receptor saturation is a very important open issue,
since the lack of a general model requires executing expensive
lab experiments for receptors characterization [12]. In addition,
receptors saturation affects drug delivery and disease modeling
[13]. However, most of research in the molecular commu-
nications either neglect the presence of individual receptors
(absorbing receiver [14]), or neglect the absorption time of
2molecules (absorbing receptors [15]). A more accurate model,
which partially addresses these shortcomings by modeling
molecules absorption via receptors with a birth-death Markov
process, is presented in [16]. However, also this model has its
shortcomings. In fact, it models receptors as a pool of servers,
which can be invoked and used when any new molecule enters
the system. Instead, receptors are isolated service elements,
and this nature must be taken into account.
Main contributions: the paper has two main contributions.
The first one is the analysis of the causes of congestion at
RX when a continuous flow of molecules is transmitted by
the TX. The second and main contribution is a queuing model
that includes these causes, which has been validated by an
extensive simulation campaign. Our idea is to model each
receptor on the RX surface as a pure loss queuing system.
Specifically, we model each receptor by an M/M/1/1 queue,
where the mean service time is the mean trafficking time.
Given the unguided diffusion of the transmitted signal, we
model the receiving nanomachine as a node with a large
number of receiving antennas (receptors), each interfaced to
a layer 2 with very high processing time (the trafficking
time) without waiting room. Thus, when the concentration of
molecules nearby the RX surface becomes excessive (channel
congestion) and a significant part of receptors are busy, also
the RX becomes congested (receiver congestion). This anal-
ogy between diffusion-based molecular communications and
wireless communications is motivated also by recent papers
dealing with multiple-input and multiple-output schemes [17]
and directional antennas [18] to build directional receivers in
the field of molecular communications, similarly as in the
wireless world.
Finally, although the queuing theory has already been used
in the field of bio-physics for modeling ligand-receptor sys-
tems [11], [19], the novel contribution of this paper consists
of using this theory for modeling receptor saturation from the
communications perspective, thus treating it as a congestion
problem in communications networks. To the best of our
knowledge, this is the first paper using this approach.
The paper is organized as follows. In section II, we illustrate
the related work in the field. Section III presents the system
model, including a detailed description of our proposed model,
which is able to capture the root causes of congestion. Nu-
merical results, which include the results of the simulation
campaign, used to validate the proposed mechanisms, are
presented in Section IV. Finally, we draw our conclusions in
Section V.
II. Background and RelatedWorks
A. Molecular communications
A complete view of a layered network architecture for
molecular communications has been proposed in [20]. Follow-
ing the layered architecture of traditional communication net-
works, such as the Open Systems Interconnection model (OSI)
and TCP/IP reference model, a formal model was developed
for each layer, and potential research directions are illustrated
for each of them. Other works explore issues related to the
high protocol layers, including connection-oriented protocols
[9], feedback-based rate control [8], network coding [21], and
security issues [22].
However, major research efforts in molecular communica-
tions are focused on the physical layer issues of different
communication media. In particular, the information capacity
and the physical features (e.g., delay, signal attenuation and
amplification) of molecular communications are studied by us-
ing random walk models [23]–[25], random walk models with
drift [26], [27], diffusion-based models [28]–[32], diffusion-
reaction-based models [33], [34], active transport models [23],
[35], and a collision-based model [36].
As for the diffusion-based models, which is the model
considered in this work, a review of different transmission
schemes is provided in [37], where the existing schemes
are classified into pulse position modulation (PPM, [26]),
concentration shift keying (CSK, [38]), and molecule shift key
(MoSK), a further proposed category which combines bursts
of different molecules to encode data. The possible trade-
off between symbol duration and communication distance is
analyzed in [39].
Some recent papers show enhanced receivers for diffusion-
based molecular communications [25], [39]–[45]. However,
these works, as most of research papers in molecular commu-
nications, do not take into account that signal reception occurs
via binding between a signal molecule and the relevant surface
receptor, and the number of receptors is typically assumed to
be so large to cover all the receiving nanomachine surface.
This is referred as the so-called absorbing receiver model [14],
in which a molecule, when gets in touch with the surface
of the RX node, is immediately absorbed and removed from
the surrounding environment. Although the absorbing receiver
model is acceptable for some processes used by cells to engulf
other cells, microvesicles, or proteins (phagocytosis and/or
pynocytosis, [46]), most of cells communications are carried
out via receptors. Thus, in some situations the assumption of
using an absorbing receiver is a very rough approximation,
since receptors are a finite resource and each nanomachine
usually has a limited, yet large, number of receptors of
a given type. A variation of the absorbing receiver model
is the receiver with absorbing receptors [15], in which a
molecule is instantaneously absorbed when it hits a compliant
receptors. Again, although this model is acceptable in some
specific situations (e.g. for modeling ions channels [47]), in
most of cases it does not, since the stochastic nature of the
ligand-receptor binding is not considered. Differently, it is
contemplated in [16], and further investigated in [48], which
also includes the trafficking time [11] in the reception process.
B. Drug delivery systems
One of the most popular topics in nanomedicine is the
targeted drug delivery, since it could be the basis for the
modern medical therapeutics. Its main goal is to provide a
localized drug delivery only where medication is needed, thus
avoiding to affect other healthy parts of the body. This is due
to the very small size of the particles delivering medicine,
which is in the order of nanometers (nanoparticles), which
allow them to diffuse into the bloodstream and across the
3vascular and interstitial barriers. Nanoparticles present ligands
on their surface, in order to improve cell targeting. In fact,
these ligands increase the chances of binding to the surface
receptors of target cells [49].
Many types of drug delivery, based on molecular com-
munications, have been proposed in the technical literature,
with both passive and active transport of molecules. For what
concerns passive transport, the most popular approach is based
on particle diffusion, with or without drift. In case the drug
delivery happens via the circulatory or lymphatic system, the
most appropriate model is the diffusion with drift, by also
considering the effect of collisions with blood cells [50], [51].
In case the drug delivery happens outside blood vessels, e.g.
in the extracellular matrix, the mere diffusion-based model
is sufficiently accurate. In case of active transport, the main
alternatives are those based on bacteria.
In order to design an efficient and targeted drug delivery, it
is essential to correctly determine the distribution of particles
over time. For this reason, the relevant research has produced
several approaches, from statistical models [52] to analytical
ones [53]. In particular, drugs delivered through bloodstream
can reach any part of the body, by passing through the
complex network of blood vessels (Particulate Drug Delivery
System, PDDS). In [53], further expanded in [54], [55], the
authors propose a specific model of the cardiovascular system,
by analyzing the peculiarities of different vessels, from the
smallest to the largest ones, thus obtaining a drug propagation
network model which takes into account even bifurcations and
junctions of vessels. The resulting model includes also the in-
dividual features of the cardiovascular system by physiological
parameters, such as the heartbeat rate profile. This model could
be useful to guarantee that the drug concentration does not
reach toxic levels in the body and it is essential for optimizing
the drug injection, by identifying the suitable injection points
that guarantee the best delivery profile for maximizing the
treatment benefits while minimizing the amount of drugs in
the other parts of the body. To this aim, it is necessary to
realize a complete control of the drug release, from the initial
release, to the suitable release rate.
A different and even more innovative model considers the
delivery from a number of nanomachines (nano-actuator),
implanted close to the target (e.g. a tumor), which bypasses the
injection through the cardiovascular system, thus minimizing
the side effects on the healthy parts of the body. A theoretical
model on the local rate control between a nano-controller
and a nano-actuator has been presented in [8]. However, this
is a high abstraction model, which does not consider fine
grained dynamics and does not explore the receiver congestion
phenomenon. Subsequently, a related communication protocol,
inspired by the TCP congestion control, has been proposed
in [9]. This protocol can control the drug release process by
using feedback messages. A challenging aspect of the protocol
operation is the usage of feedback messages, which makes the
protocol mostly suitable for environments without drift.
Drug delivery systems lay their foundations on the interac-
tions of drug molecules with the receptors at target cells [56]–
[58]. Two opposite main theories exist, namely the occupancy
theory [59] and the rate theory [60]. The former assumes that
the drug effects are maximized when all receptors at the target
are occupied by the drug, whereas the rate theory is developed
on the assumption that the excitation of a stimulant drug
is proportional to the rate of the drug-receptor combination,
rather than to the proportion of receptors occupied by the
drug. However, behavior of drugs can be quite different. For
instance, it is not always necessary to reach an occupancy of
100% of receptors to produce a full response on the target cell
[61]. In addition, it was found that a good model for describing
the effects of the drug-receptor interaction depends on the type
of drug [62]. In any case, our proposed receiver model can be
used for analyzing both of them.
III. The SystemModel
The considered drug delivery scenario consists in two
fixed bio-nanomachines, staying at a distance d between their
centers, as depicted in Fig. 1. One of them is the transmitting
node and the other is the receiver. The communication happens
by means of signal molecules released by TX, which propagate
by diffusion, modeled as Brownian motion [10]. The Brownian
motion is characterized by the diffusion coefficient, given by
D=
KbT
6piηrc,tx
. Kb is the Boltzmann constant, T is the temperature
expressed in Kelvins, η is the viscosity of the medium, and rc,tx
is the radius of the considered molecules. The shape of both
RX and TX is spherical with radius rRX and rTX , respectively.
The number of receptors deployed on the RX surface is RRX,
and they are modeled as a circular area of radius rr,rx.
The transmission is organized in bursts of molecules of size
Q, spaced in time by a short period equal to ∆t, so as to
emulate a continuous emission of drug molecules with rate
Q/∆t. The reception process at receptors is modeled as an
exponential random variable with mean Ttra f f . We assume
that the communication session can be set up and torn down
with a specific protocol, e.g. similar to the one shown in [9].
However, since our results are unaffected by the protocol used,
the latter is beyond the scope of this paper.
Let us assume that the center of TX is located at the origin
of the system of coordinates, and initially we neglect the
disturbing presence of the RX. We recall that the RX is not
absorbing, although able to capture molecules. We now solve
the diffusion equation upon the transmission an impulse of
size Q molecules at t = 0. The concentration of molecules
c(t,r), in a given point of the space at a distance r from the
center of system of coordinates and at a specific time t, can
be obtained by solving the diffusion equation (Fick’s second
law of diffusion [10]), which is
∂c(t,r)
∂t
= D∇2c(t,r), (1)
obtaining the system impulse response scaled by Q:
hQ(t,r) =
Q
(4piDt)
3
2
e
(
− r2
4Dt
)
. (2)
Since the diffusion equation is a linear equation [63], the
solution to (1) for a train of bursts of size Q spaced by a
4TX RX
d
r
RX akr(ak)r
TX
Sk
ak-1
b
Fig. 1: System model. We assume there is a circular symmetry
around the axis d.
period ∆t (
∑⌊t/∆t⌋
i=1
Qδ(t− i∆t)) and started at t = 0 is
c(t,r) =
⌊t/∆t⌋∑
i=1
hQ(t− i∆t,r) ≈
1
∆t
∫ t
0
hQ(τ,r)dτ −−−→
t→∞
Q
∆t4piDr
.
(3)
This is a significant result, although obtained with the simpli-
fying assumption of neglecting the presence of the RX node.
The arrival rate of molecules in the receiver space depends
on the concentration close to the receiver surface [16], which,
in turn, from (3), results to be inversely proportional to the
distance from the source of molecules, that is c(r) ∝ 1
r
.
As mentioned above, most of the receiver models do not
take into account the presence of receptors on the receiver
surface, and assume that the receiver can capture all compli-
ant molecules in the surrounding space (absorbing receiver).
Clearly, these models are unsuitable for detecting congestion
since it is due to the limited rate of creation of ligand-receptors
bonds, and depends on both the number of receptors RRX and
on the trafficking time Ttra f f .
In this regard, a more accurate model is the “reversible
first-order reaction” model presented in [16]. Although this
model has been proposed for a different goal, it is instructive
to review it in the perspective of congestion in molecular
communications. In addition, it allows further detailing the
system model.
A. Review of reversible first-order reaction model
According to [16], the status of the receiver at any time
t can be represented by the value of a random variable n˜(t),
which denotes the number of ligand-receptor bonds at time
t. Thus, the receiver behavior is modeled by the random
process {[n˜(t)] , t ≥ 0}. In general, n˜(t) increases when new
ligand-receptor bonds are created, and decreases due to the
internalization of these bonds [11], that is ligand molecules
assimilation. In our model, we neglect the probability of the
secondary effect of the rupture of the ligand-receptor bond be-
fore its internalization, in order to simplify the comprehension
of the main underlying phenomena. However, if needed, it can
be easily introduced in the receiver model.
The random process {[n˜(t)] , t ≥ 0} is modeled as a birth-
death, discrete-valued, continuous-time Markov process, with
n˜(t) ∈ {0,1,2, . . . ,RRX} [64]. Let pii(t) denote the probability
that the Markov chain is in state i at time t; that is, pii(t) =
P {n˜(t) = i}. This means that the system has i active ligand-
receptor bonds. Then the dynamical equations for the state
probabilities are as follows:
d
dt
pii(t) = λi−1pii−1(t)− (λi +µi)pii(t)+µi+1pii+1(t), (4)
where is noted that all the rates λi and µi are state-dependent.
In particular, we observe that
• the coefficient λi describes the bond formation rate when
the number of active bonds are i. In a queuing system, it
represents the users arrival rate when the system is in state
i. It depends upon the number of available receptors on
the cells surface, RRX − i, the concentration of molecules
close to the cells surface at a given time, c(t,r), and on
the per receptor association rate constant, k+ [16], [65].
Specifically, the constant k+ in [16] is defined as the
product of Z, which represents how frequently a collision
between a particle and an unbound receptor happens,
and FC(Ea), which is the fraction of collisions having
an energy higher than the threshold Ea, so that they can
form a bond. Clearly, it results that Z is proportional to the
average number of free receptors, that is Z ∝ (RRX −nb),
where nb is the average number of bond receptors in
steady-state conditions. In turn, nb is a function of the
average arrival rate, λa, formally defined in (16). As for
FC(Ea), in our model, each collision between a ligand
and a compliant receptor corresponds to an assimilation,
thus FC(Ea)= 1. The resulting rate is the product of these
three quantities, that is,
λi = k+ c(t,r) (RRX − i) = Zc(t,r) (RRX − i) ; (5)
• the coefficient µi describes the bond internalization rate
when the number of active bonds are i. A memoryless
model for this phenomenon is widely accepted in litera-
ture [11]. It depends upon the number of currently formed
complexes and on the average trafficking time, where
the trafficking time is a random variable exponentially
distributed with average value Ttra f f . This means that
µi = µi = i/Ttra f f . (6)
We assume that the TX node sends molecules according to
the constant pattern with rate Q/∆t. Then, in the steady state,
the arrival process at the receiver can be approximated as
a Poisson process, due to the randomness and memoryless
properties of Brownian motion. The average arrival rate λa
observed by the receiver is given by
λa =
RRX−1∑
i=0
λipii. (7)
However, in addition to the arrival rate, also the value of the
rejection rate λr is very important. In fact, since the model
consists of a pure loss queuing system with RRX servers and
state dependent arrival rate, it clearly exhibits some losses.
λr represents the rate at which a ligand-receptor bond cannot
be formed, due to hits of ligand molecules with already busy
receptors. By following a reasoning similar to the one reported
above for evaluating λi, we can say that the state dependent
rejection rate is equal to
λi,r = Z
∗c(t,r)i = λi
nbi
(RRX −nb) (RRX − i)
. (8)
5Clearly, the per state rejection rate is proportional to the
number of busy receptor, i, and to the Z∗, which represents how
frequently a collision between a particle and a busy receptor
happens, which, in turn, is obviously proportional to nb, and
thus Z∗ = Z nb
RRX−nb . Consequently, the average rejection rate λr
can be evaluated as
λr =
RRX∑
i=1
λi,rpii. (9)
B. Proposed congestion model
We model the reception process of any single receptor as
an M/M/1/1 queue (single server queueing system without
waiting room, [64]). If we consider the quantities depicted
in Fig. 1, it is easy to express the distance from the center of
TX to a generic point on the RX surface as a function of the
angle α as
r(α) =
√
(d+RRXsin(α))2+ (RRXcos(α))2, (10)
with α ∈ [−pi/2,pi/2]. As for the absorption rate of molecules
to the node RX (λ∗a), which is a measurable parameter, it is the
superposition of the rates of arrival to each receptor j, denoted
as λ∗
a, j
. Each receptor j is identified by the corresponding angle
α j and its distance from the TX center is equal to r(α j). We
denote as j=1 the receptor corresponding to α= pi/2, for which
the distance to the center of TX is d+ rRX . Considering that,
as in the previously illustrated model [16], the arrival rate
is proportional to the local concentration of molecules, and
taking into account (3), it results that
λ∗a =
RRX∑
j=1
λ∗a, j = λ
∗
a,1(d+ rRX)
RRX∑
j=1
1
r(α j)
, (11)
where λ∗a is a system parameter which can be easily measured
by the receiver. Thus, the assimilation rate for each receptor
λ∗
a, j
can be derived by λ∗a by inverting (11) and finding λ
∗
a,1
.
In an M/M/1/1 queue, given the rate of accepted traffic λa,
the rate of the rejected traffic is λr =
Ttra f f λ
2
a
1−Ttra f f λa . Thus, by using
this result for each receptor, it is easy to find the system level
rejection rate λ∗r , given by
λ∗r =
RRX∑
j=1
λ∗r, j = λ
∗
a,1(d+ rRX)
RRX∑
j=1
1
r(α j)
(
r(α j)
λ∗
a,1
(d+rRX )Ttra f f
−1
) , (12)
where λ∗
a,1
can be obtained by inversion of (11), once the
global arrival rate of molecules is known.
It is worth to note that although the system model illustrated
in Fig. 1 assumes that the target of the drug is modeled as a
spherical bio-nanomachine, in order to resemble some types
of cells, the application of the proposed model is much more
general. In more detail, the target of the drug can be modeled
as a surface with a generic shape provided with receptors.
If fact, as it appears from (11) and (12), the per-receptor
assimilation and rejection rates are functions of the receptor
distance from the center of transmission nanomachine, and can
be easily evaluated once a measure λ∗a is available.
If we assume that receptors are uniformly distributed on
the RX surface, and by using the symmetry around the axis
connecting the center of TX with the center of RX, it is
possible to find more results. By partitioning the RX surface
into RRX areas, it results that the surface surrounding each
receptor has an average size S = 4pir2
RX
/RRX. The angle α1 = β
corresponding to the receptor located at distance d+ rRX will
be equal to β = 2/
√
RRX due to geometrical considerations. If
we divide the remaining surface of half semi-sphere (that for
positive value of α, the same reasoning holds for negative
ones) in a number of spherical zones with angle ∆α, all
receptors in these zones have the same distance from the
center of TX, thus they see the same local concentration of
drug molecules, and thus the same arrival rate λ∗
a, j
. If we
assume that the area S dedicated to each receptor has roughly a
square shape, it results that S = (rRX∆α)
2, thus ∆α=
√
S /rRX =√
4pi/RRX, and the number of spherical zones F are given by
F =
pi−β
2∆α
. Since the area of each k-th spherical zone identified
by αk = k∆α is given by S k = 2pir
2
RX
(sin(k∆α)− sin((k−1)∆α))
(see also Fig. 1), the number of receptors in such a zone is
nk =
S k
S
=
RRX
(
sin(k
√
4pi/RRX)− sin((k−1)
√
4pi/RRX)
)
2
(13)
This means that (12) becomes
λ∗r = λ
∗
a,1(d+ rRX)
F+1∑
k=−F−1
nk
r(αk)
(
r(αk)
λ∗
a,1
(d+rRX )Ttra f f
−1
) , (14)
and λ∗
a,1
can be obtained by
λ∗a,1 =
λ∗a
(d+ rRX)
∑F+1
k=−F−1
nk
r(αk)
. (15)
In order to consider a different distribution of receptors, by
assuming that the symmetry with respect to d still holds, it is
enough to change the values of nk, given that the condition∑F+1
k=−F−1 nk = RRX is satisfied.
C. Application to drug delivery
In this sub-section we illustrate the application of our
congestion model to drug delivery systems. Without loss of
generality, we refer to the occupancy theory [59], since it is
the most commonly accepted theory. It says that the magnitude
of drug response depends on the occupancy ratio of receptors
by drug molecules. What we illustrate in what follows can
similarly be adapted to the rate theory.
As shown in [61], in some cases (e.g. competitive antagonist
drugs) a full drug response can be produced even at low
receptor occupancy, and it results that excess receptors, not
bound to drug molecules, are no further needed to obtain
the maximum drug response. Thus, in this case study we
assume the usage of a drug type which produces the desired
response when at least a fraction f of receptors of the target
cells are bound to the drug molecules. Thus, in order to
suitably configure the drug delivery system, the first step
consists of determining the minimum drug release rate that
allows achieving the desired percentage of bound receptors.
By using the results shown in [15], it is easy to find that a
6good approximation of the arrival rate value λo = λ
∗
a + λ
∗
r is
given by
λo = λ
∗
a+λ
∗
r =
rRX
d
RRXrr,rx
pirRX +RRXrr,rx
Q
∆t
. (16)
Thus, by applying (14) and (15) in (16), it is easy to find
a relationship between the release rate and λ∗a. In addition, by
using the Little’s law [64], it is immediate to find that the mean
number of busy receptors (servers) in the system is given by
λ∗aTtra f f , and the desired fraction f results equal to the overall
utilization coefficient ρ, which is equal to
ρ =
λ∗aTtra f f
RRX
= f . (17)
IV. Performance Evaluation
The performance of the system has been evaluated by using
the BiNS2 simulator [66], [67], which is a Java package
designed to simulate nano-scale biological communications in
3D. The approach of BiNS2 is fine grained: the position of
each element, nanomachine or molecule, is evaluated at each
simulation step, and collisions are managed according to a
partially inelastic model, described by means of the coefficient
of restitution [68]. Not only molecules, but also nanomachines
can be either fixed or mobile. The surrounding environment
can be unbounded or bounded. In the latter case, the bounding
surface can have different shapes; currently the supported ones
are sphere, cylinder, and cube, or a combination of them [51].
In addition, BiNS2 allows modeling a receiver node with a
finite number of receptors RRX . Each receptor implements a
finite, non-negligible reception time (trafficking time). When a
molecule hits one of the molecule-compliant receptors, if it is
not busy in another bond, it locks the relevant receptor for an
amount of time whose distribution of the can be selected from
a number of known statistics. In this work, the trafficking time
is exponentially distributed with average value Ttra f f , whereas
the transmission rate at TX is fixed for the whole simulation
duration. Instead, if the receptor is busy, the molecule is
bounced back as it would have hit a portion of the surface
of the receiver without receptors. In the scenario of this paper,
nanomachines are fixed, whereas molecules move according
to the Brownian motion and as results of collisions, which
can occur with nanomachines or among themselves.
The simulation reliability of BiNS2 has been assessed by
tuning simulation results with lab experiments [67]. Finally,
the BiNS2 package implements an octree-based computation
approach [67], which uses a dynamic splitting of the simulated
environment into cubes of different size in order to parallelize
the simulation, so as to benefit of the multi-thread capabilities
of modern multi-core computer architectures, and thus strongly
reducing the simulation time. In the simulation of the scenario
considered in this paper, the simulation environment is un-
bounded; however, we implemented a cubic virtual boundary
with side 1 mm to implement the octree algorithm. The
TX nanomachine is located at the center of the cube. When
molecules exit the cube, they are removed from the simulation,
in order to limit the computational burden of the simulation.
From the above description, it appears that BiNS2 implements
TABLE I: Simulation parameters
Symbol Description Value
T Temperature 310 K
e Coefficient of restitution (part. inelastic collisions) 0.95
η Viscosity 0.0011 Pl [68]
rRX Radius node RX 2.5 µm
rTX Radius node TX 2.5 µm
RRX Amount of surface receptors (node RX) 10000
rc,tx Radius emitted molecules 1.75 nm
rr,rx Receptor radius (RX) 4 nm
Ttra f f Trafficking time 2 or 4 s
∆t Emission period (TX) 20 ms
d RX-TX distance 26.5 µm
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Fig. 2: Q-Q plot of arrivals (both absorbed and rejected
molecules in intervals of 0.1 s) obtained via simulation versus
synthetic Poisson data with the same average.
exactly the receiver model that we consider in this paper. The
main simulation parameters, together with their descriptions
and values, are reported in Table I. In the next subsection,
we present the simulation results of the scenario described in
section III.
A. Numerical results
Before evaluating system performance, it is necessary to
verify the suitability of the assumption of Poisson distributed
arrivals. Fig. 2 presents the Q-Q plot of simulation data
versus synthetic Poisson data generated with the same average
value. The simulation data include both absorbed and rejected
molecules, gathered in intervals of 0.1 seconds. The resulting
agreement is evident.
From the results in sections III, it can be argued that the
concentration of molecules is higher on the portion of the
receiver surface facing the TX. In this portion of the surface,
there are a lot of molecules which cannot establish a bond
with receptors since most of them are already busy. Instead,
the concentration of molecules close to the opposite portion
of the receiver surface is much lower, since the molecules,
following the negative gradient of concentration, tend to leave
the RX node. As shown in section III-B, this phenomenon
has a significant impact also on assimilations (and rejections).
This observation is confirmed in Fig. 3, which shows the map
of assimilations for a trafficking time equal to Tta f f=4s, at
different times, corresponding to different amount of assimi-
lations. Na represents the cumulative number of assimilations
7for each receptor, and it is plotted by means of a discrete
value, chromatic scale for all the RRX receptors of RX. Each
receptor is identified by its spherical coordinates, that is the
azimuth θ, whose range is (-pi,pi] radians, and the altitude φ,
whose range is (-pi/2,pi/2] radians. The direction connecting
the center of TX and RX corresponds to (θ,φ) = (0,0). As
expected, the largest number of assimilations (i.e., Na values),
in all considered samples, is located in the region around the
center of the plot, that is (θ,φ) = (0,0), which also represents
the closest point between the RX and the TX. With respect
to (2), the presence of the RX perturbs the concentration of
molecules. In particular, those colliding with the portion of
surface with values of θ and φ close to zero continue remaining
close to the surface of the RX, due to negative gradient of the
concentration, which “pushes” them towards large values of
d. This facilitates the creation of ligand-receptor bonds on a
larger area. However, in the region with coordinates close to
(θ,φ) = (0,0), the values of Na are often more than twice the
value in the remaining of the RX surface. Since these receptors
of the RX receive a larger portion of binding attempts, they
are also responsible for most of rejections. We now show
simulation results obtained by using both the proposed model
and the one illustrated in [16], suitably adapted to calculate
the rejection rate, as described in section III-A. In order to
compare simulations with the theoretical models, we have
assumed that they have the same mean arrival rate λa = λ
∗
a
(and thus the same mean number of busy receptors). We have
evaluated the rejection rate, since λa is the only parameter
that the RX can estimate reliably. In the simulation, we have
tracked the number of rejection events, whereas the theoretical
value in (9) has been determined by evaluating the state
probabilities numerically. As for the proposed model, the rate
of rejection (i.e. unabsorbed drug molecules due to collisions
with busy receptors) is evaluated by means of (14). In addition,
in the simulation we have verified that the ratio between the
collisions of molecules with any of the deployed receptors,
either busy or not, and those with the portion of surface of the
RX not covered by receptors, closely match the theoretical
value of RRX
(rr,rx+rc,rx)
2
4r2
RX
, where rr,rx is the receptor radius, rc,tx
is the molecules radius, and rRX is the RX node radius.
Results are shown in Fig. 4. In Fig. 4.a, the ordinate axis
reports the rejection rate for the case Ttra f f = 4 seconds,
for both the simulations and the two theoretical models. The
rejection rate derived from the model in [16] and presented
in section III-A is labeled as “Symmetric”. Fig. 4.b shows
the same quantities for Ttra f f = 2 seconds. In both figures, the
abscissa reports the absorption rate measured at RX, expressed
in drug molecules per second. Both abscissa and ordinate are
expressed on a logarithmic scale. The first comment is that
the symmetric model strongly underestimates the values of
rejection rate λr, which means that it is not able to effectively
detect congestion. Instead, our proposed model exhibits an
excellent match with simulation results in all cases. This
is an expected result, since in [16] it is assumed that the
concentration of molecules is the same all over the surface of
the receiver. Instead, it could be not true, especially for low
transmission rates and for short trafficking times. In addition,
and this is the most important reason, receptors do not behave
as a pool of servers, which can be invoked and used upon a
new user enters the system (M/M/m/m model). Instead, they
are isolated service elements, and this nature must be taken
into account. Even if the symmetric model tries to mitigate
this effect, by using a state dependent arrival process, it is not
sufficient. In particular, at low Ttra f f values, the difference
between the results of the symmetric model and the simu-
lation increases, since it is expected that the RX is eager to
assimilate drug molecules and to re-present available receptors.
Nevertheless, this is true only in unlikely case of uniform
concentration. Instead, an interesting behavior appears in the
case Ttra f f=4s when the absorption rate is very high, larger
than 1000 molecules/s. In this case, as shown in Fig. 4.a, the
estimation of the rejection rate given by the symmetric model
tends to converge to the simulation values, which is also the
value estimated by our model. Also this phenomenon can be
easily explained. In fact, when the Ttra f f value increases, the
receiver is less prompt to free receptors. This means that when
the absorption rate increases beyond a threshold value, due to
a significant increase of the concentration of drug molecules
nearby RX, even if the concentration close to the receiver
surface is not homogeneous, it is so high that the limiting
factor becomes the number of free receptors (about the 50%
in average), and thus the differences between the simulation
and the two theoretical models tends to vanish. This trend is
only barely visible for the case of Ttra f f = 2s, due to the fact
that, at the maximum transmission rate, the average number
of busy receptors is still low (about 32%). In all the other
cases, the difference between the symmetric and the proposed
model is in the range of at least one order of magnitude.
Fig. 5 shows the blocking probability, evaluated as
λ∗r
λo
, where
λo = λ
∗
r +λ
∗
a is the system arrival rate. The abscissa reports the
absorption rate, expressed in molecules per second. The net
effect of the behaviors observed in the previous Fig. 4 is a
nearly liner increase of the blocking probability, as a function
of the arrival rate, which is typical of pure loss systems in
overload. Finally, Fig. 6 shows the effect of varying the total
number of receptors RRX by 20% on the rejection rate, while
keeping constant λ∗a, indicated in the abscissa. As expected,
when RRX increases, the rejection rate also decreases. Instead,
when RRX decreases, a marked increase of the rejection rate
appears. Again, this phenomenon can be explained with the
fact that receptors are not a multiplexed resource, but they are
rather multiple, single resources. By increasing the distance
between TX and RX, we have also investigated the occurrence
of any marked decrease in the rejection rate, due to the fact
that different concentration values should be less significant
for large d (see also Fig. 3). However, we have found a nearly
negligible decrease for the rate of rejected molecules with d
for Ttra f f = 4s, not reported in this paper. This is probably due
to the fact that the phenomenon visible in Fig. 3 is due to not
only to the transmission distance, but also to the disturbing
effect of the presence of the node RX itself. This is another
confirmation that, when the system absorption rate λ∗a is kept
constant, the factor with the most significant impact is the
number of receptors, since it is not a multiplexed resource.
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Fig. 3: Maps of the number of assimilations for each surface receptor (Na), as a function of its spherical coordinates, azimuth
and the altitude, for increasing numbers of total assimilation: a) 7850, b) 48761, c) 72891, and d) 117920.
B. Lesson learned towards drug delivery
In the previous subsection, we have analyzed the proposed
model through simulations. Now, we highlight some key
issues learned from this analysis, and focus on the operational
procedure for designing an effective, localized drug delivery
system.
First, in order to make use of the proposed model, it is
necessary to characterize the underlying system. This can be
done by means of lab experiments, or by using results already
present in the literature. The goal of these experiments consists
of estimating a small number of parameters, necessary for
characterizing the system behavior. These parameters are the
average trafficking time Ttra f f , and the number of surface
receptors of the considered type, RRX. Once the values of
these two parameters are known, and the TX-RX distance d
is known, it is possible to make use of the model for any
value of the emission rate
Q
∆t
in order to evaluate the average
number of busy receptors. Finally, according to the drug used,
it is necessary to know the minimum fraction of receptors to be
bound to drug molecules in order to maximize the drug effects.
As mentioned above, for some types of drug this fraction could
be quite low. For instance, in [61], the author shows that often
only 5-10% occupancy is needed to produce a full response
when agonist drugs are used. For each drug, this value can be
derived by in-vitro experiments. Thus, the final step consist of
using the results obtained in subsection III-C for estimating
the optimal drug release rate
Q
∆t
, which guarantees the desired
fraction of receptors bound to drug molecules, that is at least
f , without drug overloading. Fig. 7.a shows the percentage
of busy receptors as a function of the release rate of drug
molecules, for the trafficking time values already used in this
paper, 2s and 4s, respectively. As expected, the value of f
increases with the rate
Q
∆t
. This sublinear increase is due to
congestion. Fig. 7.b depicts the minimum release rate of drug
molecules necessary to achieve the target occupancy f , versus
the transmission range, for different values of the trafficking
time. A first comment is that the dependency of drug release
rate is nearly linear with the transmission range. In addition,
the trafficking time has a significant influence on the slope of
the release rate curve. In particular, the lower the trafficking
time, the prompter is the target cell to absorb the drug, which
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Fig. 4: Rejections as a function of the absorption rate: a) Ttra f f
equal to 4 seconds, and b) Ttra f f equal to 2 seconds.
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makes it necessary to transmit more molecules to maintain the
target occupancy f .
V. Conclusion
In this paper, we have introduced the concept of congestion
in diffusion-based molecular communications, and proposed
a model for both illustrating the dynamical behavior of
the phenomenon and analyzing the root causes of it. The
considered continuous emission of molecules is typical of
localized drug delivery systems. Our proposed model of the
receiver nanomachine includes an M/M/1/1 queue for each
receptor. This model can capture the dependency of the arrival
rate (ligand-receptor bond formation) on both transmission
range and nature of receptor. Receptors cannot be simply
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different number of receptors and trafficking times.
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molecules release rate.
considered a set of multiplexed resources such as a server pool.
They behave as isolated, multiple nano-receivers, independent
of each other. An extensive numerical analysis shows that
this model is effective in modeling congestion conditions,
especially in the range of distances typical of diffusion-based
molecular communication.
The results of this work can be used for implementing rate
control algorithms for molecular communications, in particular
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for drug delivery systems. We have detailed the operational
procedure for determining the suitable drug delivery rate from
a set of implanted emitting nanomachines, which release drug
nanoparticles close to the target cells.
In addition, since the arrival rate can be measured by the
receiver bio-nanomachine by counting the absorbed molecules,
the system can also be designed with adaptive features. In
particular, it is possible to add a further controller nanoma-
chine, which can estimate whether the used transmission rate
is optimal, and adapt its value to any change of the operational
conditions. Release rate adjustments can be triggered by using
feedback messages [8] sent when the observed deviations from
the original design conditions are significant.
The drug delivery system analyzed in this paper is analyzed
in a quasi-static environment, such as the extracellular matrix.
Drug delivery in more dynamic environments, such as blood
vessels, we will be the object of future investigations. In such
scenarios different configurations can be studied, such as fixed
transmitters, anchored to vessel wall, and mobile targets (e.g.
circulating tumor cells), or mobile transmitters and mobile
targets, or mobile transmitters and fixed targets (e.g. solid
tumors).
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